Changing trends in end-stage renal disease patients with diabetes

被引:18
作者
Lu Yimin [1 ]
Stamm, Christina [1 ]
Nobre, Dina [1 ]
Pruijm, Menno [1 ]
Teta, Daniel [1 ]
Cherpillod, Anne [2 ]
Halabi, Georges [3 ]
Phan, Olivier [4 ]
Fumeaux, Zina [5 ]
Bullani, Roberto [6 ]
Gauthier, Thierry [7 ]
Mathieu, Claudine [2 ]
Burnier, Michel [1 ]
Zanchi, Anne [1 ,8 ]
机构
[1] Univ Hosp Lausanne CHUV, Serv Nephrol, Lausanne, Switzerland
[2] Cecil Clin, Haemodialysis Unit, Lausanne, Switzerland
[3] Northern Vaud Hosp, Haemodialysis Unit, Yverdon, Switzerland
[4] Broye Intercantonal Hosp, Haemodialysis Unit, Payerne, Switzerland
[5] Nyon Hosp, Haemodialysis Unit, Nyon, Switzerland
[6] EHC Hosp, Haemodialysis Unit, Morges, Switzerland
[7] Riviera Providence Hosp, Haemodialysis Unit, Vevey, Switzerland
[8] Univ Hosp Lausanne CHUV, Serv Endocrinol Diabet & Metab, Lausanne, Switzerland
关键词
diabetes; end-stage renal disease; dialysis;
D O I
10.4414/smw.2017.14458
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Worldwide, diabetes has become the most common cause of end-stage renal disease (ESRD), yet Swiss data are largely lacking. METHODS: This observational study examined ESRD patients with diabetes mellitus (ESRD-DM) at end of 2009 and 2014. The prevalence and characteristics of ESRD-DM patients were collected in all dialysis facilities in the Canton of Vaud of Switzerland in 2009 and in 2014, and the 5-year mortality rate was assessed. RESULTS: A total of 107 and 140 ESRD-DM patients underwent dialysis at end of 2009 and 2014, respectively. Within the 5-year period a total of 167 incidental ESRDDM patients required dialysis, corresponding to an estimated incidental rate of 0.84/1000 person-years in the diabetic population. In 2009, all patients with ESRD-DM underwent haemodialysis, decreasing to 96.2% in 2014, with 3.8% on peritoneal dialysis. Age, sex, body mass index, type of diabetes, duration of diabetes, cause of ESRD, dialysis duration, dialysis frequency, vascular access, and glycosylated haemoglobin levels did not differ between 2009 and 2014. In 2014, macrovascular comorbidity was reported more often than in 2009, but not amputations. Haemoglobin level decreased significantly from 117.9 g/l to 112.3 g/l. Calcium-containing phosphate binder and angiotensin-converting enzyme inhibitor use significantly decreased, whereas iron therapy significantly increased with time. The 5-year mortality rate was 61.7%. Five-year survivors were significantly younger and had a higher body mass index. CONCLUSIONS: The growing prevalence of ESRD-DM emphasises that prevention of chronic kidney disease and its progression should be a public health priority in Switzerland.
引用
收藏
页数:7
相关论文
共 31 条
[1]   Standards of medical care in diabetes 2008 [J].
不详 .
DIABETES CARE, 2008, 31 :S12-S54
[2]  
[Anonymous], 2012, ANN REP DIAL OUTC PR
[3]   INTERNATIONAL HEALTH CARE SYSTEMS Individual Responsibility and Community Solidarity - The Swiss Health Care System [J].
Biller-Andorno, Nikola ;
Zeltner, Thomas .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (23) :2193-2197
[4]  
Breidthardt T, 2011, SWISS MED WEEKLY
[5]   Normalization of hemoglobin level in patients with chronic kidney disease and anemia [J].
Drueke, Tilman B. ;
Locatelli, Francesco ;
Clyne, Naomi ;
Eckardt, Kai-Uwe ;
Macdougall, Iain C. ;
Tsakiris, Dimitrios ;
Burger, Hans-Ulrich ;
Scherhag, Armin .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20) :2071-2084
[6]   High cardiovascular event rates occur within the first weeks of starting hemodialysis [J].
Eckardt, Kai-Uwe ;
Gillespie, Iain A. ;
Kronenberg, Florian ;
Richards, Sharon ;
Stenvinkel, Peter ;
Anker, Stefan D. ;
Wheeler, David C. ;
de Francisco, Angel L. ;
Marcelli, Daniele ;
Froissart, Marc ;
Floege, Juergen .
KIDNEY INTERNATIONAL, 2015, 88 (05) :1117-1125
[7]   Chronic kidney disease: the global challenge [J].
El Nahas, AM ;
Bello, AK .
LANCET, 2005, 365 (9456) :331-340
[8]   End-stage renal disease in the United States: An update from the United States renal data system [J].
Foley, Robert N. ;
Collins, Allan J. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (10) :2644-2648
[9]  
Golshayan D, 2002, NEPHROLOGIE, V23, P179
[10]   Increases in renal replacement therapy in Australia and New Zealand: Understanding trends in diabetic nephropathy [J].
Grace, Blair S. ;
Clayton, Philip ;
McDonald, Stephen P. .
NEPHROLOGY, 2012, 17 (01) :76-84